Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Advancements in Machine Learning and Biomarker Integration for Prenatal Down Syndrome Screening; [Dogum Oncesi Down Sendromu Taramasi Icin Makine Ogrenimi Ve Biyobelirtec Entegrasyonunda Gelismeler] Publisher



Danaei M1 ; Rashnavadi H2 ; Yeganegi M3 ; Dastgheib SA4 ; Bahrami R5 ; Azizi S6 ; Jayervand F1 ; Masoudi A7 ; Shahbazi A8 ; Shiri A9 ; Aghili K10 ; Mazaheri M11 ; Neamatzadeh H11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Obstetrics and Gynecology, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran
  4. 4. Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Shahid Akbarabadi Clinical Research Development Unit, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  8. 8. Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran
  9. 9. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  10. 10. Department of Radiology, Shahid Rahnamoun Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  11. 11. Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Source: Turkish Journal of Obstetrics and Gynecology Published:2025


Abstract

The use of machine learning (ML) in biomarker analysis for predicting Down syndrome exemplifies an innovative strategy that enhances diagnostic accuracy and enables early detection. Recent studies demonstrate the effectiveness of ML algorithms in identifying genetic variations and expression patterns associated with Down syndrome by comparing genomic data from affected individuals and their typically developing peers. This review examines how ML and biomarker analysis improve prenatal screening for Down syndrome. Advancements show that integrating maternal serum markers, nuchal translucency measurements, and ultrasonographic images with algorithms, such as random forests and deep learning convolutional neural networks, raises detection rates to above 85% while keeping false positive rates low. Moreover, non-invasive prenatal testing with soft ultrasound markers has increased diagnostic sensitivity and specificity, marking a significant shift in prenatal care. The review highlights the importance of implementing robust screening protocols that utilize ultrasound biomarkers, along with developing personalized screening tools through advanced statistical methods. It also explores the potential of combining genetic and epigenetic biomarkers with ML to further improve diagnostic accuracy and understanding of Down syndrome pathophysiology. The findings stress the need for ongoing research to optimize algorithms, validate their effectiveness across diverse populations, and incorporate these cutting-edge approaches into routine clinical practice. Ultimately, blending advanced imaging techniques with ML shows promise for enhancing prenatal care outcomes and aiding informed decision-making for expectant parents. © 2025 The Author.